Stockreport

Athira Pharma Reports Third Quarter 2025 Financial Results and Provides Business Update

Athira Pharma, Inc.  (ATHA) 
PDF Continuing to explore strategic alternatives focusing on maximizing stockholder value   Presented results from Phase 1 clinical trial of ATH-1105 in healthy volunteers [Read more]